National Cancer Center Japan has partnered with Precision Medicine Asia and Paradigm Health to develop a streamlined system to facilitate trials.

NEW YORK – Beam Therapeutics on Tuesday disclosed initial clinical data, including one patient death, in a Phase I/II trial of its investigational sickle cell disease (SCD) gene-editing therapy ...

NEW YORK – Inify Laboratories on Tuesday said it has partnered with researchers at Karolinska Institutet to improve prostate cancer diagnosis through artificial intelligence-driven image analysis.

The government payor said it will separately pay for specialized diagnostic radiopharmaceuticals without transitional pass-through payment status.

The FDA has cleared an investigational new drug application enabling the company to begin a Phase I trial of HG202 in patients with the eye disorder.

The company will use the funds to enroll a registrational trial for its investigational gene therapy NGN-401 for Rett Syndrome.

A half-dozen hospital systems plan to implement the tool, which combs through patient medical records to identify those ...

The drugmaker emphasized plans to move further away from singular reliance on Keytruda while reporting solid sales growth in ...

The efficacy seen in a small study, especially in GNAS-mutated tumors, could influence care, but the rarity of the cancer is ...

Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.

Broad Institute and Northwestern University researchers are encouraging others to examine noncoding genes, when investigating ...

When doctors and other types of providers provide pretest genetic testing education to patients, it allows Clearview's ...